Stay updated on CP-690,550 in Crohn's Disease: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 in Crohn's Disease: Safety & Efficacy Clinical Trial page.

Latest updates to the CP-690,550 in Crohn's Disease: Safety & Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check31 days agoChange DetectedUpdate to version v3.1.0 with removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and deletion of related sections from the prior version (v3.0.2).SummaryDifference0.4%

- Check45 days agoChange DetectedRevision updated to v3.0.2; the previous v3.0.1 tag and the 'Back to Top' element were removed.SummaryDifference0.2%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as detailed drug information for Tofacitinib, while some previous location names and terms have been removed.SummaryDifference6%

- Check74 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to CP-690,550 in Crohn's Disease: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 in Crohn's Disease: Safety & Efficacy Clinical Trial page.